Introduction
relative survival rates are 59% and 48%, respectively [1] . Currently, surgery, radiation and chemotherapy are three major modalities applied in the conventional treatment of this malignant disorder [2] . Chemotherapy (pre-or post-surgery) is beneficial for local control and survival improvement, although it does not always induce a substantially positive response [3] . In fact, the lack of effective chemotherapeutic drug results in a high death rate in patients with OSCC [4] . Therefore, effective chemotherapy medicines for OSCC are highly desirable and demanded.
Honokiol (HNK) is a small organic molecule purified from magnolia species. Evidence has demonstrated that HNK has a variety of pharmacological effects, such as anti-inflammatory [4] , antithrombotic [5] , anti-arrhythmic [4] , antioxidative [6] and anxiolytic [7] . Indeed, it has been reported that HNK could inhibit cell proliferation and induce cytotoxicity in a variety of cell lines derived from cancers such as prostate, blood vessel, blood, lung, colon, liver, etc. [8] [9] [10] [11] [12] [13] . However, little is known about the antitumor effects of HNK on OSCC. Therefore, in this study we chose OSCC cell lines to investigate its possible function on OSCC cell lines in vitro and explore the possible mechanism for its inhibitory effects, trying to lay the basis for the potential application in the clinical practice of OSCC treatment.
Materials and Methods

Cell line and Reagents
Two oral sqamous cell carcinoma cell lines, HSC-3 and HSC-4, were purchased from Japanese Collection of Research Bioresources (JCRB) Cell Bank, and maintained in DMEM medium (Gibco, USA) supplemented with 10% heat inactivated fetal bovine serum (APP, Italian) at 37 in 5% CO ℃ 2 . HNK was purchased from Sikehua Biotechnology Co. (Chengdu, China), and dissolved in dimethyl sulfoxide (DMSO) at the stock concentration of 20 g·L -1
. The latter was further diluted in culture medium at the final DMSO concentration <0.1% and the HNK maximum concentration of 20 μg·mL -1 . 5-fluorouracil (5-Fu) was purchased from China National Pharmaceutical Group Co. (Shanghai, China), dissolved in ddH 2 O at the stock concentration of 10 g·L -1 .
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
Cell growth and viability were assessed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The kit was purchased from Sigma Chemical Corporation, USA. In brief, the cells (1 × 10 4 in 100 μL) were seeded on 96-well plates in triplicate. Following a culture at 37 for 24 ℃ h, the medium was replaced with fresh medium at various concentrations of HNK (10, 15 Co., USA) [14] .
Propidium iodide assay
Cells (3 × 10 5 in 2 mL) were seeded on six-well plates. Following a 24h-culture at 37 , the media were repla ℃ -ced with fresh medium at various concentrations of HNK (10, 15 [15] .
TUNEL assay
The DeadEnd TM Fluorometric TUNEL (TdT-mediated dUTP-biotin nick end labeling) system (Promega Inc., USA) was used. In brief, cells (3 × 10 5 in 2 mL) were seeded on six-well plates. Following a 24 h-culture at 37 , the medium was replaced with fresh medium at ℃ 15 μg·mL -1 of HNK in a final volume of 2 mL. Cells were further incubated at 37
for 48 ℃ h, and washed with PBS and fixed by 4% methanol-free formaldehyde solution in PBS at 4 for 25 ℃ min, and then further washed with PBS and permeablized by 0.2% Triton X-100 in PBS for 5 min at room temperature. Finally the staining was carried out according to the manufacturer's instructions and fluorescence was visualized to count TUNEL-positive cells with Leica DMI 6000B microscope (Leica DMI 6000B, Leica Co., Germany) [16] .
DNA ladder assay
To detect DNA fragments, OSCC cells were exposed to 15 ) and ethanol (99.5%), dissolved in a loading buffer (Takara, Japan), and illustrated the DNA fragmentation under ultraviolet light (Bio-Rad, American) [17] after the electrophoresis on 2% agarose gels (Gene-Tech Co., Shanghai, China).
Flow cytometry assay
Apoptotic rates of the cells were analyzed by flow cytometry (FCM) using Annexin V-FITC/PI Apoptosis Detection Kit (R & D systems, Abingdon, United Kingdom) according to the manufacturer's instructions. In brief, flow cytometry assay was performed on a FACSAria flow cytometry system (BD Biosciences). Data were analyzed by using BD FACSDiva software, and presented as dot plots showing fluorescence intensity of Annexin-V fluorescein isothiocyanate (Annexin-V FITC) and PI [18] .
Statistical analysis
Values were given as mean ± SD. Statistical comparisons were made by Student's t-test, and P<0.05 was taken as the significance.
Results
HNK inhibited the OSCC cell growth
MTT assays were carried out to evaluate the cell viability upon treatment with three different concentrations of HNK (10, 15 or 20 μg·mL -1 , individually), or 20 μg·mL -1 5-Fu (the control), which are based on our pilot studies (Data not shown) and previous report [17] . A pronounced increase in growth inhibition occurred after the treatment with those agents (Figures 1, 2 ), although the low dosage (10 μg·mL -1 ) group of HNK also tended to slightly enhancing growth at the early stage in an unknown reason. Those phenomena demonstrated the ability in inhibitory efficiency of HNK on OSCC cells. The positive control (20 μg·mL -1 5-Fu) demonstrated the same results, confirmed the inhibition effects.
To further confirm our observations, a PI assay was performed to visualize the survival OSCC cells and to evaluate cancer cell killing efficiency in those treatment via HNK or 5-Fu. Consistent with data in MTT assay, these agents resulted in a marked decrease in the number of cells with statistic significance (P<0.01) (Figures 1,  2) . 
The inhibitory effects of HNK on OSCC cells showed a time and dosage dependent manner
The MTT values were detected from 0 h to 72 h with 12 h or 24 h interval at different time points to test whether the inhibitory effect of HNK on OSCC cells was in a time ( Figure 2 ) dependent manner, and the results demonstrated that the inhibitory effects of cell proliferation were obvious after the exposure of cells to HNK in both cell lines, and the increase in killing efficiency significantly concurred with the time course, although the value was a slight tendency of the cell number to go up at the lower dosage of HNK (10 μg·mL -1 ) at the early treatment stage (before 24 h).
The MTT assays were also performed to evaluate whether the inhibitory effect of HNK to concur with the dosage increase at three different concentrations of 10, 15 or 20 μg·mL 
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The inhibitory power of HNK to OSCC cells also showed a dosage dependent manner
The inhibitory power of HNK to OSCC cells was measured by using the ratio of the cell number of OSCC cells between the treatment of different concentrations of HNK (10, 15, HNK. These results were consistent with the data from MTT, which confirmed the inhibitory power of HNK to OSCC cells.
HNK induced apoptosis in OSCC cells evidenced via morphological changes and DNA fragmentation detection
According to MTT results, we chose 15 μg·mL -1 of HNK dosage group to further observe the possible changes in terms of morphology posterior to the treatment of HNK. Under the fluorescence reverse microscope, the HNK-treated cells clearly exhibited morphological features of apoptosis ( Figure 4A ) such as karyopyknosis, meniscus as well as cell shrinkage, etc. [19] . 
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A more sensitive assay, fluorescence TUNEL system, was also conducted to detect the DNA strand breaks by labeling free 3′-OH termini. In HNK treated cells, TUNELpositive cells were presented ( Figure 4A ). A degradation of chromosomal DNA into small internucleosomal fragments was remarkably evidenced by the formation of 180-200 bp DNA ladders on agarose gels (Figure 4B ), the hallmark of cells undergoing apoptosis. Meanwhile, no DNA ladders were observed in the control cultures ( Figure 4B) .
These results strongly suggested that HNK induced an apoptotic cell death in OSCC cells.
HNK induced apoptosis in OSCC cells, evidenced by flow cytometry assays
To further confirm that the inhibition of HNK on the growth of OSCC cells was caused by apoptosis, the percentage of apoptotic cells in HNK-or 5-Fu-treated OSCC cells was evaluated by the flow cytometry assay after the double staining of Annexin-V fluorescein isothiocyanate (FITC) and propidium iodide (PI). The ratio of apoptotic cells increased in both of the OSCC cell lines with the increase of the concentration of HNK as compared with the blank control ( Figure 5) . Furthermore, the ratio of the apoptotic cell proportion (early apoptosis cells and late apoptosis cells, 
Discussion
Oral squamous cell carcinoma (OSCC) is one of the most common malignancies that remain incurable with current therapies. As a particular type of head and neck squamous cell carcinoma, OSCC patients have been commonly treated with cisplatin (or carboplatin) and/or 5-Fu, traditionally [20] . However, drug resistance often recurs, accompanied by distressing symptoms [21] . The response rate to most commonly used cytotoxic agents was only about 30%-40% in large studies [22] . Previous studies have demonstrated that the acquired drug resistance of cancer cells was associated with the alterations in apoptosis [23] . In other words, drug resistance to currently used chemotherapeutics was proposed to be partly mediated by the ability of the tumor cells to circumvent apoptosis [24] [25] [26] . Therefore, the inhibition of apoptosis is taken as a major contributing factor to drug-resistance in cancer cells. From this point of view, new treatment approaches with different mechanisms of apoptosis induction are all urgently being explored to overcome the limited effectiveness of current treatment modalities for OSCC. It appears that exploiting the apoptotic potential of OSCC would lead to contemporary therapies that might be less toxic to normal cells due to their physiologically-controlled survival pathways.
HNK, a natural product isolated from magnolia grandiflora, has multiple pharmacologic actions including antioxidative, anti-angiogenesis, and antitumor effects and so on [6-7, 10, 17, 27] . Previous studies suggest that growth inhibition by HNK resulted from the induction of apoptosis in several cell lines [9] [10] [27] [28] [29] . A further study reported that HNK induces a necrotic cell death through the mitochondrial permeability transition pore [30] . Moreover, it is known for its low toxicity in normal peripheral blood mononuclear cell (PBMNC) or primary cultured human cells [17, [31] [32] [33] . However, little evidence is available for its effects on OSCC cells.
We have first tested the effects of HNK on oral squamous cell carcinoma cell models in the current study by MTT and PI assays to explore the inhibition potential of HNK on OSCC cells growth and proliferation. We have found that HNK inhibits the growth and proliferation of OSCC cells with a dosage-and time-dependent manner, which is consistent with the previous reports in other cells [17] .
Furthermore, we have proposed the inhibitory power as a novel index by using the ratio of the cell number or the inhibitory effects of OSCC cells between the treatment of HNK to 5-Fu (positive group) treatment via MTT assays, PI assays, FCM assays to further illustrate the ability of HNK on OSCC cells for the first time.
From this novel index, we have further confirmed and enhanced the preliminary results that HNK inhibits the growth and proliferation of OSCC cells in a dosage-and time-dependent manner, which have obtained solely via MTT, PI, or FCM assays. In fact, this novel strategy could be used for the assessment of the inhibitory effects of any new drug that have potential to be candidate reagents for the treatment of oral squamous carcinoma or other tumors compared with conventional ones such as 5-Fu or cisplatin.
Moreover, we have found that HNK induced apoptosis in vitro in OSCC cells, evidenced by PI assay, TUNEL assay, DNA ladder assay, and FCM assay, suggesting the HNK may be a novel treatment agent to overcome drug-resistance in OSCC cancer cells, although more studies in vivo will be warranted.
On the other hand, some of previous studies have explored two modes of mechanisms in which HNK takes to induce the apoptosis or necrosis in the other cancer cell models [8-13, 17, 27, 33-34] . In brief, HNK have demonstrated the potentiating to activate the extrinsic pathways of cell apoptosis in tumors with p53 depletion or mutation (i.e. the activation of caspase 3, 7, and 9 have been noted). At the same time, the alternative (intrinsic) pathway (associated with mitochondrial dysfunction, reactive oxygen generation, and necrosis) may be more important in tumors with wild-type p53. Whether HNK takes the same mechanisms or any other novel pathways to make its antitumor activity in OSCC is currently under further studies via in vitro and in vivo experiments in our group.
In summary, our study has demonstrated that growth inhibition by HNK resulted from the induction of apoptosis in OSCC cell lines in vitro. Our findings suggest that HNK may be a promising agent that can be further studied as a novel treatment agent for human OSCC.
